Amgen · company speakers →
provided insights into AMG 410, a small molecule inhibitor of the KRAS signaling pathway that is often mutated in a variety of cancer types and represents a promising target, especially in pancreatic cancer.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →